StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Full clarus update

<< Previous

Bullboard Posts

Next >>

Comment by gojotv!on Apr 07, 2021 2:35pm

165 Views

Post# 32950659

RE:RE:Full clarus update

Aye, there's the rub... SZLS is NOT abandoning the employer focus as Clarus believes.
They have downgraded their target on a misconception.
Do your DD, folks.
Until Clarus adjusts their analysis, there's a buying opp here that will turn into a basher feeding frenzy.
Don't get eaten in the fray.
GLTA!

Mykndrsn wrote: Atkinson is confused. The employer market has NOT been abandoned. It was there expressed desire that SZLS go this route to provide assistance after a positive test. Someone (Rebecca) needs to get him some facts asap. He's not dealing from a full deck.

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide